Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial.

BMC Cancer · 2013 · PMC3691625 · PMID 23782513

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

The authors concluded that nimotuzumab shows a clear trend towards efficacy in MGMT non-methylated glioblastoma patients together with an excellent safety profile [ 23 ].

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.